Ferric carboxymaltose in treating moderate iron deficiency anaemia in pregnancy

Background: Anaemia is most common abnormality seen during pregnancy accounts for 20% of all maternal deaths.Most common cause is iron deficiency anaemia in pregnancy.Since compliance to oral iron therapy is poor and results unpredictable, parenteral iron is better option.Objective: To find out the role of ferric carboxymaltose in moderate iron deficiency anaemia in pregnancy.Method: It is a cross-sectional analytical study of 40 pregnant women in gestational age 14-28 week with moderate anaemia in Department of Obstetrics and Gynaecology, Assam Medical College and Hospital, Dibrugarh.Results: Within short span of 4 weeks, IV FCM increased haemoglobin by 1.56gm/dl, serum iron by 48.77gm/dl and MCV by 12.10fl (p<0.05 in all).Conclusion: In a resource limitted setting, single dose administration, rapid improvement of haematological parameters makes FCM as the best option for management of IDA in pregnancy.